Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Initial and Sustained Immunity to SARS-CoV-2 Measured by Serologic Assays on an Automated Immunoassay System

NCT04562285 is registered in ClinicalTrials.gov with Henry Ford Health System as lead sponsor.

NCT NCT04562285
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04562285 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Initial and Sustained Immunity to SARS-CoV-2 Measured by Serologic Assays on an Automated Immunoassay System
Lead sponsor
Henry Ford Health System
Phase
Observational
Overall status
Completed
Start date
June 23, 2020
Completion date
June 7, 2024
Enrollment
829 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19